Sanofi Consumer Healthcare is pushing back on a recommendation that it discontinue the “#1 doctor-recommended” claim for its Zantac 360° heartburn medicine in a case brought by competitor Johnson & ...

GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old reflux medication Zantac was contaminated with a suspected carcinogen. The ...

Delaware's highest court said on Tuesday it will hear an appeal by GSK GSK.L and other drug makers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Over the counter Zantac used for acid reflux and heartburn. The future of thousands of lawsuits alleging that recalled heartburn medication Zantac causes cancer is becoming more uncertain after an ...